3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Gastrointestinal Stromal Tumors
2
Philadelphia Chromosome
1
Melanoma
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
5
fludarabine phosphate
3
Vincristine
3
Methotrexate
3
Etoposide
3
pegaspargase
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Leucovorin
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Dobesilate
2
venetoclax
1
prednylidene
1
hydrocortisone hemisuccinate
1
fludarabine
1
exifone
1
deltacortene
1
calaspargase pegol
1
azathiopurine
1
aldesleukin
1
Thioguanine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Imatinib Mesylate
×
30 days
×
Clear all
No trials found.